Clinical trial
Evaluation of Enhanced Absorption of a Micellar Curcumin Formulation (curQ+) or a Liposomal Curcumin Formulation Versus 95% Curcumin Extract in Healthy Individuals
NCT06177483 is registered in ClinicalTrials.gov with ESM Technologies, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Enhanced Absorption of a Micellar Curcumin Formulation (curQ+) or a Liposomal Curcumin Formulation Versus 95% Curcumin Extract in Healthy Individuals
- Lead sponsor
- ESM Technologies, LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2024
- Completion date
- September 10, 2024
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bioavailability